Skip to content

Downstream Process Development

Including development and optimization of monoclonal antibodies (mAbs).

Downstream Process Development

OPM provides clients with purification development and optimization of monoclonal antibodies, bispecific/trispecific antibodies, enzymes, vaccines, cytokines, fusion protein, and other protein.

Extensive experience

  • 30+ projects of downstream process development, and some projects have accomplished FDA and NMPA IND applications.

Professional team

  • Project leaders have 8~15 years of experience.

On-time delivery

  • Deliver in 2-3 months on average

High yield

  • mAb > 80%
    BsAbs > 60%

Advanced equipments

  • High-throughput screening and rapid protein preparation equipments, etc.

Services offered

  • Standardized development process.
  • Technology transfer, and process scale-up.
  • IND application and CTD material writing service.

Workflow

Downstream PD_workflow